Alphabet Receives Another Mini-Tender Offer from Tutanota, Doesn't Endorse Offer
By Denny Jacob
Alphabet received an unsolicited mini-tender offer from Tutanota to purchase up to 350,000 shares of the company's Class C stock for $180 a share in cash.
The parent company of Google said in a securities filing that the offer represents less than 0.01% of the shares of its outstanding Capital C shares as of Sept. 3. It didn't endorse the mini-tender offer and expressed no opinions on any actions shareholders may want to take.
Alphabet's Class C shares currently trade around $163.26. The stock is up about 16% on the year.
Alphabet received a similar offer in July from the private investment company, which it also didn't endorse.
Mini tender offers seek to acquire less than 5% of a company's shares, letting the bidder skirt the sizable information disclosures required by the U.S. Securities and Exchange Commission on all other tender offers.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
September 24, 2024 09:11 ET (13:11 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks